Jennie W. Taylor

Jennie W. Taylor

Neurosurgery | Neurology

400 Parnassus Ave.
Eighth Floor
San Francisco, CA 94143

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 99 publications

A Shared Neoantigen Comes of Age: Lessons from Long-Term Follow-up of IDH1 Vaccination.

A Shared Neoantigen Comes of Age: Lessons from Long-Term Follow-up of IDH1 Vaccination.

Journal: Neuro-oncology

Published: August 03, 2026

Tele-cognitive rehabilitation for adult lower-grade glioma: An interim prospective pilot feasibility study.

Tele-cognitive rehabilitation for adult lower-grade glioma: An interim prospective pilot feasibility study.

Journal: Neuro-oncology practice

Published: March 09, 2026

Measuring what matters: Tumor volumes in-IDH-mutant gliomas.

Measuring what matters: Tumor volumes in-IDH-mutant gliomas.

Journal: Neuro-oncology

Published: February 12, 2026

A Genomically Tailored Multiagent Precision Medicine Clinical Trial for Adults with Recurrent Glioblastoma.

A Genomically Tailored Multiagent Precision Medicine Clinical Trial for Adults with Recurrent Glioblastoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 28, 2025

Understanding and imaging PHGDH-driven intrinsic resistance to mutant IDH inhibition in gliomas.

Understanding and imaging PHGDH-driven intrinsic resistance to mutant IDH inhibition in gliomas.

Journal: bioRxiv : the preprint server for biology

Published: September 15, 2025

Creating a neuro-oncology framework for an empowered and engaged peer volunteer patient community.

Creating a neuro-oncology framework for an empowered and engaged peer volunteer patient community.

Journal: Neuro-oncology practice

Published: August 05, 2025

IL6 Supports Development of an Immunosuppressive Microenvironment and Resistance to Therapy in Glioblastoma.

IL6 Supports Development of an Immunosuppressive Microenvironment and Resistance to Therapy in Glioblastoma.

Journal: Cancer research

Published: July 08, 2025

IL-6 underlies microenvironment immunosuppression and resistance to therapy in glioblastoma.

IL-6 underlies microenvironment immunosuppression and resistance to therapy in glioblastoma.

Journal: Cancer research

Published: July 08, 2025

Establishing the content validity of patient-reported outcome measures used in neuro-oncology based on the WHO ICF framework: Part of the RANO-PRO initiative.

Establishing the content validity of patient-reported outcome measures used in neuro-oncology based on the WHO ICF framework: Part of the RANO-PRO initiative.

Journal: Neuro-oncology

Published: April 28, 2025

Spatial synaptic connectivity underlies oligodendroglioma evolution and recurrence.

Spatial synaptic connectivity underlies oligodendroglioma evolution and recurrence.

Journal: Research square

Published: April 16, 2025

IL-6 underlies microenvironment immunosuppression and resistance to therapy in glioblastoma.

IL-6 underlies microenvironment immunosuppression and resistance to therapy in glioblastoma.

Journal: bioRxiv : the preprint server for biology

Published: March 31, 2025

Longitudinal profiling of IDH-mutant astrocytomas reveals acquired RAS-MAPK pathway mutations associated with inferior survival.

Longitudinal profiling of IDH-mutant astrocytomas reveals acquired RAS-MAPK pathway mutations associated with inferior survival.

Journal: Neuro-oncology advances

Published: March 07, 2025

Showing 1-12 of 99

Last Updated: 09/26/2026